Granules India receives USFDA approval for its generic Lisdexamfetamine Dimesylate capsules, indicated for the treatment of ADHD and Binge Eating Disorder in adults and children. Jan 30, 2025 14:05 ...

Granules India Ltd share price was down by -1.44% from the previous closing price of ₹564.45. Who are peers of Granules India Ltd? The peers of Granules India Ltd are Sun Pharmaceuticals ...

Granules India Ltd., incorporated in the year 1991, is a Mid Cap company (having a market cap of Rs 13,703.32 Crore) operating in Pharmaceuticals sector. Granules India Ltd. key Products/Revenue ...